Correction to: Pharmacokinetic and Pharmacodynamic Studies of Elacestrant, A Novel Oral Selective Estrogen Receptor Degrader, in Healthy Post-Menopausal Women

Lignende værker

• Pharmacokinetic and Pharmacodynamic Studies of Elacestrant, A Novel Oral Selective Estrogen Receptor Degrader, in Healthy Post-Menopausal Women
  af: Conlan, Maureen G., et al.
  Udgivet: (2020)
• Pharmacokinetic and pharmacodynamic properties of orally administered torsemide in healthy horses
  af: Agne, Gustavo F., et al.
  Udgivet: (2018)
• Pharmacokinetics, Pharmacodynamics, Safety, and Tolerability of Oral Venglustat in Healthy Volunteers
  af: Peterschmitt, M. Judith, et al.
  Udgivet: (2020)
• Phase I Study of Elacestrant (RAD1901), a Novel Selective Estrogen Receptor Degrader, in ER-Positive, HER2-Negative Advanced Breast Cancer
  af: Bardia, Aditya, et al.
  Udgivet: (2021)
• A phase 1b study evaluating the effect of elacestrant treatment on estrogen receptor availability and estradiol binding to the estrogen receptor in metastatic breast cancer lesions using (18)F-FES PET/CT imaging
  af: Jager, Agnes, et al.
  Udgivet: (2020)